Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Palo Alto Investors (company) patents

Patents where

Current Assignee

Name

Palo Alto Investors (company)

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7149574 Treatment of conditions through electrical modulation of the autonomic nervous system	Patent 7149574 was granted and assigned to Palo Alto Investors (company) on December, 2006 by the United States Patent and Trademark Office.		Palo Alto Investors (company)	United States Patent and Trademark Office	7149574	December 12, 2006
‌ US Patent 7363076 Treatment of conditions through modulation of the autonomic nervous system	Patent 7363076 was granted and assigned to Palo Alto Investors (company) on April, 2008 by the United States Patent and Trademark Office.		Palo Alto Investors (company)	United States Patent and Trademark Office	7363076	April 22, 2008
‌ US Patent 11338120 Methods and devices for treating parasympathetic bias mediated conditions	Patent 11338120 was granted and assigned to Palo Alto Investors (company) on May, 2022 by the United States Patent and Trademark Office.	Palo Alto Investors (company)	Palo Alto Investors (company)	United States Patent and Trademark Office	11338120	May 24, 2022
‌ US Patent 7899527 Treatment of conditions through modulation of the autonomic nervous system during at least one predetermined menstrual cycle phase	Patent 7899527 was granted and assigned to Palo Alto Investors (company) on March, 2011 by the United States Patent and Trademark Office.		Palo Alto Investors (company)	United States Patent and Trademark Office	7899527	March 1, 2011
‌ US Patent 7676269 Treatment of female fertility conditions through modulation of the autonomic nervous system	Patent 7676269 was granted and assigned to Palo Alto Investors (company) on March, 2010 by the United States Patent and Trademark Office.		Palo Alto Investors (company)	United States Patent and Trademark Office	7676269	March 9, 2010
‌ US Patent 8121690 Treatment of female fertility conditions through modulation of the autonomic nervous system	Patent 8121690 was granted and assigned to Palo Alto Investors (company) on February, 2012 by the United States Patent and Trademark Office.		Palo Alto Investors (company)	United States Patent and Trademark Office	8121690	February 21, 2012
‌ US Patent 9821003 Methods and devices for treating conditions associated with autonomic dysfunction	Patent 9821003 was granted and assigned to Palo Alto Investors (company) on November, 2017 by the United States Patent and Trademark Office.	Palo Alto Investors (company)	Palo Alto Investors (company)	United States Patent and Trademark Office	9821003	November 21, 2017
‌ US Patent 9326887 Methods and devices for treating conditions associated with autonomic dysfunction	Patent 9326887 was granted and assigned to Palo Alto Investors (company) on May, 2016 by the United States Patent and Trademark Office.	Palo Alto Investors (company)	Palo Alto Investors (company)	United States Patent and Trademark Office	9326887	May 3, 2016
‌ US Patent 7738952 Treatment of conditions through modulation of the autonomic nervous system	Patent 7738952 was granted and assigned to Palo Alto Investors (company) on June, 2010 by the United States Patent and Trademark Office.		Palo Alto Investors (company)	United States Patent and Trademark Office	7738952	June 15, 2010
‌ US Patent 11382513 Methods and compositions for treating a condition in a subject		Palo Alto Investors (company)	Palo Alto Investors (company)	United States Patent and Trademark Office	11382513	July 12, 2022
‌ US Patent 8247450 Linoleic acid active agents for enhancing probability of becoming pregnant	Patent 8247450 was granted and assigned to Palo Alto Investors (company) on August, 2012 by the United States Patent and Trademark Office.		Palo Alto Investors (company)	United States Patent and Trademark Office	8247450	August 21, 2012
‌ US Patent 8491459 Expandable vessel harness for treating vessel aneurysms	Patent 8491459 was granted and assigned to Palo Alto Investors (company) on July, 2013 by the United States Patent and Trademark Office.		Palo Alto Investors (company)	United States Patent and Trademark Office	8491459	July 23, 2013
‌ US Patent 7767713 Linoleic acid active agents for enhancing probability of becoming pregnant	Patent 7767713 was granted and assigned to Palo Alto Investors (company) on August, 2010 by the United States Patent and Trademark Office.		Palo Alto Investors (company)	United States Patent and Trademark Office	7767713	August 3, 2010
‌ US Patent 8691877 Methods and compositions for treating a disease condition in a subject	Patent 8691877 was granted and assigned to Palo Alto Investors (company) on April, 2014 by the United States Patent and Trademark Office.		Palo Alto Investors (company)	United States Patent and Trademark Office	8691877	April 8, 2014
‌ US Patent 11383084 Treatment of dermatological conditions via neuromodulation	Patent 11383084 was granted and assigned to Palo Alto Investors (company) on July, 2022 by the United States Patent and Trademark Office.	Palo Alto Investors (company)	Palo Alto Investors (company)	United States Patent and Trademark Office	11383084	July 12, 2022
‌ US Patent 7966072 Methods and compositions for treating obesity-hypoventilation syndrome	Patent 7966072 was granted and assigned to Palo Alto Investors (company) on June, 2011 by the United States Patent and Trademark Office.		Palo Alto Investors (company)	United States Patent and Trademark Office	7966072	June 21, 2011
‌ US Patent 8722016 Methods of identifying xenohormetic phenotypes and agents	Patent 8722016 was granted and assigned to Palo Alto Investors (company) on May, 2014 by the United States Patent and Trademark Office.		Palo Alto Investors (company)	United States Patent and Trademark Office	8722016	May 13, 2014
‌ US Patent 11480562 Methods of identifying xenohormetic phenotypes and agents		Palo Alto Investors (company)	Palo Alto Investors (company)	United States Patent and Trademark Office	11480562	October 25, 2022
‌ US Patent 11389534 Methods of treating a subject for a condition	Patent 11389534 was granted and assigned to Palo Alto Investors (company) on July, 2022 by the United States Patent and Trademark Office.	Palo Alto Investors (company)	Palo Alto Investors (company)	United States Patent and Trademark Office	11389534	July 19, 2022
‌ US Patent 8788041 Methods and compositions for treating a disease condition in a subject	Patent 8788041 was granted and assigned to Palo Alto Investors (company) on July, 2014 by the United States Patent and Trademark Office.		Palo Alto Investors (company)	United States Patent and Trademark Office	8788041	July 22, 2014
‌ US Patent 10426950 Methods and devices for treating parasympathetic bias mediated conditions	Patent 10426950 was granted and assigned to Palo Alto Investors (company) on October, 2019 by the United States Patent and Trademark Office.	Palo Alto Investors (company)	Palo Alto Investors (company)	United States Patent and Trademark Office	10426950	October 1, 2019
‌ US Patent 11179423 Methods of enhancing female fertility	Patent 11179423 was granted and assigned to Palo Alto Investors (company) on November, 2021 by the United States Patent and Trademark Office.	Palo Alto Investors (company)	Palo Alto Investors (company)	United States Patent and Trademark Office	11179423	November 23, 2021
‌ US Patent 8909340 Methods and devices for treating conditions associated with autonomic dysfunction	Patent 8909340 was granted and assigned to Palo Alto Investors (company) on December, 2014 by the United States Patent and Trademark Office.		Palo Alto Investors (company)	United States Patent and Trademark Office	8909340	December 9, 2014
‌ US Patent 11020051 Methods of enhancing homeostatic capacity in a subject by modulating homeostatic system synchrony, and devices for use in practicing the same	Patent 11020051 was granted and assigned to Palo Alto Investors (company) on June, 2021 by the United States Patent and Trademark Office.	Palo Alto Investors (company)	Palo Alto Investors (company)	United States Patent and Trademark Office	11020051	June 1, 2021
‌ US Patent 9320894 Methods and compositions for treating a renal associated condition in a subject	Patent 9320894 was granted and assigned to Palo Alto Investors (company) on April, 2016 by the United States Patent and Trademark Office.	Palo Alto Investors (company)	Palo Alto Investors (company)	United States Patent and Trademark Office	9320894	April 26, 2016

Results per page:

45 results

0 selected

45 results

0 selected